Evidence map›Paper›PMID 39001685›Full record

ReviewImmunological reviews2024

The right educational environment: Oral tolerance in early life.

Talia R Cheifetz, Kathryn A Knoop

Abstract readReview
In one paragraph

Review in Immunological reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Early life infection withGut microbes · 2025
    Article
  3. RORγt eTACs mediate oral tolerance and Treg induction.The Journal of experimental medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Talia R CheifetzDepartment of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
Kathryn A KnoopDepartment of Immunology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-2007-3066

Funding

Immune Outcomes to Neonatal Antigen Delivery in the IntestineR01DK134366 · NIDDK · MAYO CLINIC ROCHESTER · PI Kathryn A Knoop · 2023 to 2026
$1.5M
NIDDK Multidisciplinary Predoctoral Training in Discovery and Translational ResearchT32DK124190 · NIDDK · MAYO CLINIC ROCHESTER · PI DANIEL D BILLADEAU, MARK A. MC NIVEN · 2020 to 2026
$1.3M
NIDDK NIH HHS R01 DK134366NIDDK NIH HHS T32 DK124190
6 · The paper itself

Abstract

Oral tolerance promotes the suppression of immune responses to innocuous antigen and is primarily mediated by regulatory T cell (Tregs). The development of oral tolerance begins in early life during a "window of tolerance," which occurs around weaning and is mediated by components in breastmilk. Herein, we review the factors dictating this window and how Tregs are uniquely educated in early life. In early life, the translocation of luminal antigen for Treg induction is primarily dictated by goblet cell-associated antigen passages (GAPs). GAPs in the colon are negatively regulated by maternally-derived epidermal growth factor and the microbiota, restricting GAP formation to the "periweaning" period (postnatal day 11-21 in mice, 4-6 months in humans). The induction of solid food also promotes the diversification of the bacteria such that bacterially-derived metabolites known to promote Tregs-short-chain fatty acids, tryptophan metabolites, and bile acids-peak during the periweaning phase. Further, breastmilk immunoglobulins-IgA and IgG-regulate both microbial diversity and the interaction of microbes with the epithelium, further controlling which antigens are presented to T cells. Overall, these elements work in conjunction to induce a long-lived population of Tregs, around weaning, that are crucial for maintaining homeostasis in adults.

Indexed as

Immune ToleranceT-Lymphocytes, RegulatoryWeaningAnimalsGastrointestinal MicrobiomeGoblet CellsHumansMiceMilk, Humanearly lifemicrobiotaregulatory T cellstolerance

Identifiers

PMID39001685
PMCPMC11436309

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.